53 related articles for article (PubMed ID: 22149977)
1. Adalimumab in budesonide and methotrexate refractory collagenous colitis.
Münch A; Ignatova S; Ström M
Scand J Gastroenterol; 2012 Jan; 47(1):59-63. PubMed ID: 22149977
[TBL] [Abstract][Full Text] [Related]
2. Filgotinib for the Treatment of Refractory Collagenous Colitis.
Shibuya T; Nagahara A
J Crohns Colitis; 2024 Jun; 18(6):973-974. PubMed ID: 38055831
[No Abstract] [Full Text] [Related]
3. Effectiveness of Non-Budesonide Therapies in Management of Microscopic Colitis: A Systematic Review and Meta-analysis.
Rehde A; Hendel SK; Juhl CB; Gubatan J; Nielsen OH
Drugs; 2023 Jul; 83(11):1027-1038. PubMed ID: 37358712
[TBL] [Abstract][Full Text] [Related]
4. Microscopic colitis: an update.
Fărcaş RA; Grad S; Dumitraşcu DL
Med Pharm Rep; 2022 Oct; 95(4):370-376. PubMed ID: 36506610
[TBL] [Abstract][Full Text] [Related]
5. Microscopic colitis: Etiopathology, diagnosis, and rational management.
Nielsen OH; Fernandez-Banares F; Sato T; Pardi DS
Elife; 2022 Aug; 11():. PubMed ID: 35913459
[TBL] [Abstract][Full Text] [Related]
6. Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician.
Saleh A; Ansari U; Abughazaleh S; Glassner K; Abraham BP
Biologics; 2022; 16():67-83. PubMed ID: 35747234
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and Management of Microscopic Colitis in Pediatric Patients.
Khushal S; Oliva-Hemker M
Paediatr Drugs; 2022 May; 24(3):217-233. PubMed ID: 35501559
[TBL] [Abstract][Full Text] [Related]
8. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations.
Miehlke S; Guagnozzi D; Zabana Y; Tontini GE; Kanstrup Fiehn AM; Wildt S; Bohr J; Bonderup O; Bouma G; D'Amato M; Heiberg Engel PJ; Fernandez-Banares F; Macaigne G; Hjortswang H; Hultgren-Hörnquist E; Koulaouzidis A; Kupcinskas J; Landolfi S; Latella G; Lucendo A; Lyutakov I; Madisch A; Magro F; Marlicz W; Mihaly E; Munck LK; Ostvik AE; Patai ÁV; Penchev P; Skonieczna-Żydecka K; Verhaegh B; Münch A
United European Gastroenterol J; 2021 Feb; 9(1):13-37. PubMed ID: 33619914
[TBL] [Abstract][Full Text] [Related]
9. Single-centre experience with anti-tumour necrosis factor treatment in budesonide-refractory microscopic colitis patients.
Daferera N; Hjortswang H; Ignatova S; Münch A
United European Gastroenterol J; 2019 Nov; 7(9):1234-1240. PubMed ID: 31700636
[TBL] [Abstract][Full Text] [Related]
10. Development of collagenous colitis in inflammatory bowel disease: two case reports and a review of the literature.
Saad RE; Shobar RM; Jakate S; Mutlu EA
Gastroenterol Rep (Oxf); 2019 Jun; 7(3):218-222. PubMed ID: 31217987
[TBL] [Abstract][Full Text] [Related]
11. Case report: Pentoxifylline treatment in microscopic colitis.
Cotter TG; Kamboj AK; Hicks SB; Tremaine WJ; Loftus EV; Pardi DS
Medicine (Baltimore); 2017 Nov; 96(46):e8355. PubMed ID: 29145246
[TBL] [Abstract][Full Text] [Related]
12. Current Approach to the Evaluation and Management of Microscopic Colitis.
Cotter TG; Pardi DS
Curr Gastroenterol Rep; 2017 Feb; 19(2):8. PubMed ID: 28265892
[TBL] [Abstract][Full Text] [Related]
13. Epithelial barrier dysfunction in lymphocytic colitis through cytokine-dependent internalization of claudin-5 and -8.
Barmeyer C; Erko I; Awad K; Fromm A; Bojarski C; Meissner S; Loddenkemper C; Kerick M; Siegmund B; Fromm M; Schweiger MR; Schulzke JD
J Gastroenterol; 2017 Oct; 52(10):1090-1100. PubMed ID: 28138755
[TBL] [Abstract][Full Text] [Related]
14. Budesonide-Related Iatrogenic Cushing's Syndrome in Microscopic Colitis.
Tripathi K; Dunzendorfer T
ACG Case Rep J; 2017; 4():e5. PubMed ID: 28138449
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Management of Microscopic Colitis.
Pardi DS
Am J Gastroenterol; 2017 Jan; 112(1):78-85. PubMed ID: 27897155
[TBL] [Abstract][Full Text] [Related]
16. Successful use of adalimumab in patient with treatment-refractory microscopic colitis.
Anderson RJ; Makins R
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27530873
[TBL] [Abstract][Full Text] [Related]
17. Optimal management of collagenous colitis: a review.
O'Toole A
Clin Exp Gastroenterol; 2016; 9():31-9. PubMed ID: 26929656
[TBL] [Abstract][Full Text] [Related]
18. VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial.
Rohatgi S; Ahuja V; Makharia GK; Rai T; Das P; Dattagupta S; Mishra V; Garg SK
BMJ Open Gastroenterol; 2015; 2(1):e000018. PubMed ID: 26462271
[TBL] [Abstract][Full Text] [Related]
19. Microscopic colitis: A review of etiology, treatment and refractory disease.
Park T; Cave D; Marshall C
World J Gastroenterol; 2015 Aug; 21(29):8804-10. PubMed ID: 26269669
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and patterns and predictors of response to therapy in collagenous and lymphocytic colitis.
Colussi D; Salari B; Stewart KO; Lauwers GY; Richter JR; Chan AT; Ricciardiello L; Khalili H
Scand J Gastroenterol; 2015; 50(11):1382-8. PubMed ID: 25997458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
